The Pharmacy Times® Pain Management resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, among other items that pharmacists will find valuable.
What can we help you find?
Participants with severe withdrawal symptoms were more likely to be younger, longtime and frequent users of cannabis, and to have worse mental health.
Cannabis use and cannabinoids influence various immune disorders and treatments, mostly via CB2 regulation, according to a virtual session at the at the ASHP 2020 Midyear meeting.
According to research conducted at Rush University Medical Center, opioid use may increase patients’ risk of developing pancreatic cancer.
A pilot study published today in Addiction found that a collaborative approach to treating opioid use disorder that relies heavily on community pharmacists is feasible and may increase adherence and participant satisfaction.
Decreases in prescription opioid volume over the past 9 years have been driven by changes in clinical use, regulatory, and reimbursement policies, and in progressively more restrictive legislation enacted since 2012.
Monitoring outpatient prescribing patterns has been a major challenge for the Lifespan health system in Rhode Island, since it has over 1.5 million electronic prescriptions written annually.
The COVID-19 Pandemic has compounded the opioid crisis.
The FDA-approved generic is therapeutically equivalent to Mallinckrodt Pharmaceuticals’ acetaminophen injection product (Ofirmev).
The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.
According to the study results, women interested in medical cannabis reported marginally lower levels of support from their primary care provider and significantly less support from specialist physicians.
Webinar participants discuss best practices for pharmacists with patients contending with both issues.
Children’s Hospital Los Angeles Surgeon Establishes First-Ever Guidelines for Pediatric Opioid Prescribing
A CDC report reveals that approximately 9% of teens between the ages of 15 and 19 received an opioid prescription in 2018.